🔎 Trials Near Me

Home › Breast Cancer › NCT05438511

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2):

* Breast cancer survivor, patient advocate or key healthcare personnel

  * Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  * \>12 months of employment at the affiliated institution
  * Administrative or clinical involvement in the delivery of breast cancer care services.
* Age 18 years and above
* Permanent residents or citizens of Tanzania
* Participant and/or LAR willing and able to consent
* Fluent in Swahili and/or English by self-report

Participant Exclusion Criteria:

* Key stakeholder not residing at their particular institutions during data collection will be excluded.

Eligibility criteria for Chart Reviews (Aim 1)

Inclusion Criteria for chart review:

* Age 18 years and above
* Permanent residents or citizens of Tanzania
* Received breast cancer diagnosis

Exclusion Criteria for chart review:

* Participants less than 18 years of age

About the study

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

What is being tested

Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 85 · Started: Apr 13, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05438511

Locations in the U.S.

New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.